Bughaw, Marnidette B.

HRN: 08-80-94  Sex: Female

Patient Encounter


AMS Audit List

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
05/27/2022
CEFUROXIME 500MG (TAB)
05/27/2022
06/03/2022
ORAL
500mg
Q12
Prophylaxis For Soft Tissue Injury Sec To MVA
Waiting Final Action 
08/01/2022
CEFUROXIME 750MG (VIAL)
08/01/2022
08/01/2022
IVT
1.5g
Single Dose
For STAT CS
Waiting Final Action 
08/01/2022
CEFUROXIME 750MG (VIAL)
08/01/2022
08/02/2022
IVT
1.5g
Q8
S/P LTCS With BTL
Waiting Final Action 
08/05/2022
CEFUROXIME 500MG (TAB)
08/05/2022
08/12/2022
ORAL
500mg
BID
SP CS
Waiting Final Action 

AMS Audit Form


Start Date: End Date:

Indication:

              

Type of Infection:

                             

           

Compliance to guidelines:



Initial appropriateness:



 If inappropriate:

           

Final appropriateness:



 If inappropriate:

              

Overall appropriateness: